Roche Corleen M. 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
Roche Corleen M.
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-08-06+150,000→ 150,000 total→ Common stock (150,000 underlying) - Award
Stock Option (right to buy)
2025-08-06+300,000→ 300,000 totalExercise: $2.58Exp: 2035-08-06→ Common stock (300,000 underlying)
Footnotes (2)
- [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.